Guardant Health

Biotechnology

Guardant Health pioneered liquid biopsy technology that detects cancer through blood tests rather than invasive tissue biopsies. The company's tests guide treatment decisions for advanced cancer patients and screen for early-stage cancer. Guardant's blood-based approach makes genomic profiling accessible to more patients and enables longitudinal monitoring.

The Biology of Business

Sign up to be notified when the book is available to order.

Notify Me